Skip to search formSkip to main contentSkip to account menu

Alprazolam

Known as: 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-, Alprazolan, Alprazolam [Chemical/Ingredient] 
A triazolobenzodiazepine agent with anxiolytic, sedative-hypnotic and anticonvulsant activities. Alprazolam binds to a specific site distinct from… 
National Institutes of Health

Related topics

Related topics

33 relations
24 HR Alprazolam 1 MG Extended Release Oral TabletAgoraphobiaAlprazolam 0.25 MG Oral TabletAlprazolam 1 MG Disintegrating Oral Tablet

Narrower (10)

4-hydroxyalprazolamAlproxCassadanD-65MT

Broader (5)

Anti-Anxiety AgentsBenzodiazepineGABA ModulatorsHypnotics and Sedatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.
OBJECTIVE The authors examined the effectiveness of virtual reality exposure augmented with D-cycloserine or alprazolam, compared… 
Review
2007
Review
2007
Models and mechanisms of anxiety: evidence from startle studies
  • C. Grillon
  • Psychopharmacology
  • 2007
  • Corpus ID: 2901128
RationalePreclinical data indicates that threat stimuli elicit two classes of defensive behaviors, those that are associated with… 
Highly Cited
2007
Highly Cited
2007
Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports
Review
2004
Review
2004
The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials.
This article provides a critical review of the assumptions and findings of studies used to establish psychotherapies as… 
Review
2003
Review
2003
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.
Review
2000
Review
2000
Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
Drug interactions occur when the efficacy or toxicity of a medication is changed by administration of another substance… 
Review
1997
Review
1997
The olfactory bulbectomized rat as a model of depression: an update.
Highly Cited
1993
Highly Cited
1993
Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia
A cross-national randomised trial of alprazolam for chronic panic disorder with agoraphobia was run. Compared with previous… 
Highly Cited
1988
Highly Cited
1988
Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Sixteen female outpatients with borderline personality disorder and prominent behavioral dyscontrol, but without a current… 
Highly Cited
1988
Highly Cited
1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
Following promising preliminary evidence, the benzodiazepine-derivative alprazolam was studied in a large, placebo-controlled… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License